Efficacy of Once‐Daily Administration of Udenafil for 24 Weeks on Erectile Dysfunction: Results from a Randomized Multicenter Placebo‐Controlled Clinical Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1743-6109|12|5|1194-1201

ISSN： 1743-6095

Source： THE JOURNAL OF SEXUAL MEDICINE, Vol.12, Iss.5, 2015-05, pp. : 1194-1201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy of tadalafil in improving sexual satisfication and overall satisfication in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials

By Rosen Raymond C.   Shabsigh Ridwan   Kuritzky Louis   Wang Wei Christine   Sides Gregory D.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1701-1709

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 699-702

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 7, 2015-07 ,pp. : 1046-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: A randomized controlled trial

By Techapornroong Malee   Suankratay Chusana  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 10, 2007-12 ,pp. : 896-901

Informa Healthcare

Access to resources Recommend Favorite

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1739-1749

John Wiley & Sons Inc

Access to resources Recommend Favorite